Home > Insider Trading > Filing (0001093557-18-000192)

Filing Details

Accession Number:: 0001093557-18-000192
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-12 21:17:34
Reporting Period:: 2018-09-10

Accepted Time:: 2018-09-12 21:17:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286858	R Kevin Sayer	6340 Sequence Drive San Diego CA 92121	President, Ceo & Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-09-10	11,161	$4.58	346,332	No	4	M	Direct
Common Stock	Disposition	2018-09-10	1,500	$142.31	344,832	No	4	S	Direct
Common Stock	Disposition	2018-09-10	5,900	$143.35	338,932	No	4	S	Direct
Common Stock	Disposition	2018-09-10	3,761	$144.04	335,171	No	4	S	Direct
Common Stock	Disposition	2018-09-10	7,532	$143.76	327,639	No	4	S	Direct
Common Stock	Disposition	2018-09-10	6,802	$143.76	320,837	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-09-10	11,161	$0.00	11,161	$4.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,484	2010-05-19	2019-05-19	No	4	M	Direct

Footnotes

Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.
On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $141.77 to $142.72. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $142.78 to $143.77. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $143.78 to $144.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.